Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-08

Clinical Trial Update: A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of LY2951742 in mild to moderate knee osteoarthritis was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2951742

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoarthritis, Knee | Phase 2 | Status: TERMINATED | Results posted: 2018-11-08